Balchem Market Capitalization from 2010 to 2025
| BCPC Stock | USD 173.59 8.02 4.84% |
Check Balchem financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Balchem's main balance sheet or income statement drivers, such as Depreciation And Amortization of 66.3 M, Interest Expense of 17.3 M or Selling General Administrative of 143.3 M, as well as many indicators such as Price To Sales Ratio of 5.87, Dividend Yield of 0.0035 or PTB Ratio of 2.98. Balchem financial statements analysis is a perfect complement when working with Balchem Valuation or Volatility modules.
Balchem | Market Capitalization |
Latest Balchem's Market Capitalization Growth Pattern
Below is the plot of the Market Cap of Balchem over the last few years. It is Balchem's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Balchem's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 5.65 B | 10 Years Trend |
|
Market Cap |
| Timeline |
Balchem Market Capitalization Regression Statistics
| Arithmetic Mean | 3,021,147,726 | |
| Geometric Mean | 1,935,705,400 | |
| Coefficient Of Variation | 54.10 | |
| Mean Deviation | 1,443,016,228 | |
| Median | 2,665,119,695 | |
| Standard Deviation | 1,634,495,368 | |
| Sample Variance | 2671575.1T | |
| Range | 4.8B | |
| R-Value | 0.93 | |
| Mean Square Error | 405557.4T | |
| R-Squared | 0.86 | |
| Slope | 318,063,178 | |
| Total Sum of Squares | 40073626.6T |
Balchem Market Capitalization History
About Balchem Financial Statements
Balchem stakeholders use historical fundamental indicators, such as Balchem's Market Capitalization, to determine how well the company is positioned to perform in the future. Although Balchem investors may analyze each financial statement separately, they are all interrelated. For example, changes in Balchem's assets and liabilities are reflected in the revenues and expenses on Balchem's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Balchem. Please read more on our technical analysis and fundamental analysis pages.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York. Balchem Cp operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1382 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Balchem offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Balchem's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Balchem Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Balchem Stock:Check out the analysis of Balchem Correlation against competitors. For information on how to trade Balchem Stock refer to our How to Trade Balchem Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Specialty Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Balchem. If investors know Balchem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Balchem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.258 | Dividend Share 0.87 | Earnings Share 3.92 | Revenue Per Share | Quarterly Revenue Growth 0.049 |
The market value of Balchem is measured differently than its book value, which is the value of Balchem that is recorded on the company's balance sheet. Investors also form their own opinion of Balchem's value that differs from its market value or its book value, called intrinsic value, which is Balchem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Balchem's market value can be influenced by many factors that don't directly affect Balchem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Balchem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Balchem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Balchem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.